Cellular Biomedicine Group, Inc.

Size: px
Start display at page:

Download "Cellular Biomedicine Group, Inc."

Transcription

1 SECURITIES & EXCHANGE COMMISSION EDGAR FILING Cellular Biomedicine Group, Inc. Form: 8-K Date Filed: Corporate Issuer CIK: Symbol: CBMG SIC Code: 2836 Copyright 2014, Issuer Direct Corporation. All Right Reserved. Distribution of this document is strictly prohibited, subject to the terms of use.

2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2014 CELLULAR BIOMEDICINE GROUP, INC. (Exact name of registrant as specified in its charter) Delaware (State or other Jurisdiction of (Commission File Number) (IRS Employer Identification No.) Incorporation) 530 University Avenue, #17 Palo Alto, California (Address of Principal Executive Offices) (Zip Code) Registrant s telephone number, including area code: (650) (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR e-4(c))

3 Item 2.05 Item 2.06 Costs Associated with Exit or Disposal Activities. Material Impairments On June 23, 2014, the board of directors of Cellular Biomedicine Group, Inc. (the Company ) decided to discontinue the Company s legacy consulting business segment and to focus the Company s operations exclusively on its biomedicine business, acquired in February The decision resulted from a comprehensive review of the Company s long-term business strategy. The Company expects to classify the consulting business as discontinued operations and to record in the second quarter of 2014 (i) a one-time charge of approximately $852,000 in severance costs and related taxes and (ii) impairment for goodwill of approximately $3.3 million relating to the consulting business. Additionally, approximately $20,000 in medical benefits to be paid to employees affiliated with the consulting business is expected to be recorded in the third quarter of On June 30, 2014, the Company issued a press release announcing these actions. A copy of the press release is attached hereto as Exhibit In this Current Report on Form 8-K (this "Current Report"), the Company discusses and makes statements based on currently available information regarding its intentions, beliefs, current expectations and projections regarding the Company's future operations and performance, including with respect to severance and employee-related cash charges and impairment charges. Certain of these statements may constitute "forward-looking" statements as that term is defined in the Private Securities Litigation Reform Act of The Company cautions investors that such forward-looking statements are not guarantees of future performance. Risks and uncertainties are inherent in the Company's future performance. For more information regarding the risks and uncertainties of the Company's business, see "Risk Factors" in the Company's Form 10-K filed with the Securities and Exchange Commission ("SEC") on April 15, 2014 as well as other reports filed by the Company with the SEC from time to time. The Company assumes no obligation to update this Current Report or the information contained herein, except as required by law. Item Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release, dated June 30,

4 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cellular Biomedicine Group, Inc. Date: July 31, 2014 By: /s/ Bizuo (Tony) Liu Bizuo (Tony) Liu Chief Financial Officer 3

5 Exhibit 99.1 Cellular Biomedicine Group Announces Discontinuation of Consulting Business Segment PALO ALTO, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (CBMG) (the "Company"), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced the discontinuation of the Company's consulting business segment. The consulting business is expected to be classified as discontinued operations, effective July 1, As a result, the Company expects to record a one-time pre-tax cash charge of approximately $840,000 in the second quarter 2014 resulting from severance to be paid to employees affiliated with the consulting business. "After a circumspect review by management and the Board of Directors, our decision to discontinue operating the legacy consulting business should remove any performance variability associated with this segment," said Dr. William (Wei) Cao, Chief Executive Officer of Cellular Biomedicine Group. "We also believe that the consulting business no longer fits into our long-term strategy and vision. As such, we will focus our resources on becoming a world-class, pure-play biotechnology company bringing therapies to improve the health of patients in China. By optimizing our resources, we believe the scalability of our biomedicine business will deliver long-term value to our partners, patients and shareholders," added Dr. Cao. The consulting business' securities will remain on the Company's balance sheet. Keith Wong and Norm Klein, the consulting business' current management team will assist and ensure a smooth discontinuation of our consulting operations. About Cellular Biomedicine Group Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers. Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: Forward-Looking Statements Statements in this press release relating to plans, strategies, trends, specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "expects," "plans," "intends," "estimates," "potential," or "continue," or similar terms or the negative of these terms. Although CBMG believes the expectations reflected in the forward-looking statements are reasonable, they cannot guarantee that future results, levels of activity, performance or achievements will be obtained. CBMG does not have any obligation to update these forward-looking statements other than as required by law. Contact: Sarah Kelly Director of Corporate Communications, CBMG

National American University Holdings, Inc.

National American University Holdings, Inc. SECURITIES & EXCHANGE COMMISSION EDGAR FILING National American University Holdings, Inc. Form: 8-K Date Filed: 2015-08-13 Corporate Issuer CIK: 1399855 Copyright 2015, Issuer Direct Corporation. All Right

More information

JACOBS ENGINEERING GROUP INC /DE/

JACOBS ENGINEERING GROUP INC /DE/ JACOBS ENGINEERING GROUP INC /DE/ FORM 8-K (Current report filing) Filed 04/29/14 for the Period Ending 04/28/14 Address 155 NORTH LAKE AVENUE PASADENA, CA 91101 Telephone 6265783500 CIK 0000052988 Symbol

More information

VISA INC. FORM 8-K. (Current report filing) Filed 02/27/15 for the Period Ending 02/27/15

VISA INC. FORM 8-K. (Current report filing) Filed 02/27/15 for the Period Ending 02/27/15 FORM 8-K (Current report filing) Filed 02/27/15 for the Period Ending 02/27/15 Address P.O. BOX 8999 SAN FRANCISCO, CA 94128-8999 Telephone (415) 932-2100 CIK 0001403161 Symbol V SIC Code 7389 - Business

More information

Cord Blood America, Inc.

Cord Blood America, Inc. SECURITIES & EXCHANGE COMMISSION EDGAR FILING Cord Blood America, Inc. Form: 8-K Date Filed: 2008-01-31 Corporate Issuer CIK: 1289496 Symbol: CBAI SIC Code: 8071 Fiscal Year End: 12/31 Copyright 2014,

More information

FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K. Summit State Bank (Exact name of registrant as specified in its charter)

FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K. Summit State Bank (Exact name of registrant as specified in its charter) FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

More information

JER INVESTORS TRUST INC (JERT) 8-K. Current report filing Filed on 01/29/2009 Filed Period 01/28/2009

JER INVESTORS TRUST INC (JERT) 8-K. Current report filing Filed on 01/29/2009 Filed Period 01/28/2009 JER INVESTORS TRUST INC (JERT) 8-K Current report filing Filed on 01/29/2009 Filed Period 01/28/2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant

More information

Cord Blood America, Inc.

Cord Blood America, Inc. SECURITIES & EXCHANGE COMMISSION EDGAR FILING Cord Blood America, Inc. Form: 8-K Date Filed: 2013-05-20 Corporate Issuer CIK: 1289496 Symbol: CBAI SIC Code: 8071 Fiscal Year End: 12/31 Copyright 2014,

More information

FXCM INC. FORM 8-K. (Current report filing) Filed 09/09/15 for the Period Ending 09/03/15

FXCM INC. FORM 8-K. (Current report filing) Filed 09/09/15 for the Period Ending 09/03/15 FXCM INC. FORM 8-K (Current report filing) Filed 09/09/15 for the Period Ending 09/03/15 Address 55 WATER ST. FL 50 NEW YORK, NY 10041 Telephone 6464322241 CIK 0001499912 Symbol FXCM SIC Code 6200 - Security

More information

BRIDGEPOINT EDUCATION INC

BRIDGEPOINT EDUCATION INC BRIDGEPOINT EDUCATION INC FORM 8-K (Current report filing) Filed 11/12/13 for the Period Ending 11/08/13 Address 13500 EVENING CREEK DR. #600 SAN DIEGO, CA 92128 Telephone 858-668-2586 CIK 0001305323 Symbol

More information

HOME LOAN SERVICING SOLUTIONS, LTD.

HOME LOAN SERVICING SOLUTIONS, LTD. HOME LOAN SERVICING SOLUTIONS, LTD. FORM DEFA14A (Additional Proxy Soliciting Materials (definitive)) Filed 04/24/15 Telephone (345) 945-3727 CIK 0001513161 Symbol HLSS SIC Code 6162 - Mortgage Bankers

More information

CERIDIAN CORPORATION

CERIDIAN CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

APPLE INC FORM 8-K. (Current report filing) Filed 06/06/14 for the Period Ending 06/06/14

APPLE INC FORM 8-K. (Current report filing) Filed 06/06/14 for the Period Ending 06/06/14 APPLE INC FORM 8-K (Current report filing) Filed 06/06/14 for the Period Ending 06/06/14 Address ONE INFINITE LOOP CUPERTINO, CA 95014 Telephone (408) 996-1010 CIK 0000320193 Symbol AAPL SIC Code 3571

More information

BIO KEY INTERNATIONAL INC

BIO KEY INTERNATIONAL INC SECURITIES & EXCHANGE COMMISSION EDGAR FILING BIO KEY INTERNATIONAL INC Form: 8-K Date Filed: 2011-03-16 Corporate Issuer CIK: 1019034 Symbol: BKYI Copyright 2014, Issuer Direct Corporation. All Right

More information

U S PHYSICAL THERAPY INC /NV

U S PHYSICAL THERAPY INC /NV U S PHYSICAL THERAPY INC /NV FORM 8-K (Current report filing) Filed 08/04/14 for the Period Ending 08/04/14 Address 1300 WEST SAM HOUSTON PARKWAY SUITE 300 HOUSTON, TX 77043 Telephone 7132977000 CIK 0000885978

More information

ONCOTHYREON INC. FORM 424B3. (Prospectus filed pursuant to Rule 424(b)(3)) Filed 12/22/10

ONCOTHYREON INC. FORM 424B3. (Prospectus filed pursuant to Rule 424(b)(3)) Filed 12/22/10 ONCOTHYREON INC. FORM 424B3 (Prospectus filed pursuant to Rule 424(b)(3)) Filed 12/22/10 Address 2601 FOURTH AVENUE SUITE 500 SEATTLE, WA 98121 Telephone (206) 801-2100 CIK 0001412067 Symbol ONTY SIC Code

More information

ABM INDUSTRIES INC /DE/

ABM INDUSTRIES INC /DE/ ABM INDUSTRIES INC /DE/ FORM 8-K (Current report filing) Filed 10/14/11 for the Period Ending 10/11/11 Address 551 FIFTH AVENUE SUITE 300 NEW YORK, NY 10176 Telephone 212 297-0200 CIK 0000771497 Symbol

More information

GSV CAPITAL CORP. FORM 8-K. (Current report filing) Filed 04/28/15 for the Period Ending 04/28/15

GSV CAPITAL CORP. FORM 8-K. (Current report filing) Filed 04/28/15 for the Period Ending 04/28/15 GSV CAPITAL CORP. FORM 8-K (Current report filing) Filed 04/28/15 for the Period Ending 04/28/15 Address 2925 WOODSIDE ROAD WOODSIDE, CA 94062 Telephone (650) 235-4777 CIK 0001509470 Symbol GSVC Industry

More information

INFOSPACE INC FORM 8-K. (Current report filing) Filed 12/21/06 for the Period Ending 12/21/06

INFOSPACE INC FORM 8-K. (Current report filing) Filed 12/21/06 for the Period Ending 12/21/06 INFOSPACE INC FORM 8-K (Current report filing) Filed 12/21/06 for the Period Ending 12/21/06 Address 601 108TH AVE NE SUITE 1200 BELLEVUE, WA 98004 Telephone 4258821602 CIK 0001068875 Symbol INSP SIC Code

More information

INCONTACT, INC. FORM 8-K. (Current report filing) Filed 03/25/15 for the Period Ending 03/23/15

INCONTACT, INC. FORM 8-K. (Current report filing) Filed 03/25/15 for the Period Ending 03/23/15 INCONTACT, INC. FORM 8-K (Current report filing) Filed 03/25/15 for the Period Ending 03/23/15 Address 7730 S. UNION PARK AVE., SUITE 500 NONE MIDVALE, UT 84047 Telephone (801) 320-3300 CIK 0001087934

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

EXPEDIA, INC. FORM 8-K. (Current report filing) Filed 11/14/14 for the Period Ending 11/13/14

EXPEDIA, INC. FORM 8-K. (Current report filing) Filed 11/14/14 for the Period Ending 11/13/14 EXPEDIA, INC. FORM 8-K (Current report filing) Filed 11/14/14 for the Period Ending 11/13/14 Address 333 108TH AVENUE NE BELLEVUE, WA 98004 Telephone (425) 679-7200 CIK 0001324424 Symbol EXPE SIC Code

More information

JER INVESTORS TRUST INC (JERT) 8-K. Current report filing Filed on 04/11/2007 Filed Period 04/11/2007

JER INVESTORS TRUST INC (JERT) 8-K. Current report filing Filed on 04/11/2007 Filed Period 04/11/2007 JER INVESTORS TRUST INC (JERT) 8-K Current report filing Filed on 04/11/2007 Filed Period 04/11/2007 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant

More information

UNITED THERAPEUTICS CORP

UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP FORM 8-K (Current report filing) Filed 11/13/14 for the Period Ending 11/11/14 Address 1040 SPRING ST SILVER SPRING, MD 20910 Telephone 3016089292 CIK 0001082554 Symbol UTHR SIC

More information

Delaware 000-50703 14-1839426 (State or other jurisdiction of incorporation)

Delaware 000-50703 14-1839426 (State or other jurisdiction of incorporation) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 16, 2014 (Date

More information

QUALCOMM INC/DE FORM 8-K. (Current report filing) Filed 09/30/15 for the Period Ending 09/28/15

QUALCOMM INC/DE FORM 8-K. (Current report filing) Filed 09/30/15 for the Period Ending 09/28/15 QUALCOMM INC/DE FORM 8-K (Current report filing) Filed 09/30/15 for the Period Ending 09/28/15 Address 5775 MOREHOUSE DR SAN DIEGO, CA 92121 Telephone 8585871121 CIK 0000804328 Symbol QCOM SIC Code 3663

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

DELTA TUCKER HOLDINGS, INC.

DELTA TUCKER HOLDINGS, INC. DELTA TUCKER HOLDINGS, INC. FORM 8-K (Current report filing) Filed 10/30/14 for the Period Ending 10/30/14 Address 13601 NORTH FREEWAY, SUITE 200 FORT WORTH, TX 76177 Telephone 571-722-0210 CIK 0001514226

More information

FORM 8-K. CREATIVE REALITIES, INC. (Exact name of registrant as specified in its charter)

FORM 8-K. CREATIVE REALITIES, INC. (Exact name of registrant as specified in its charter) 8-K 1 f8k091514_creativerealities.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 13, 2012 Date

More information

IMS HEALTH HOLDINGS, INC.

IMS HEALTH HOLDINGS, INC. IMS HEALTH HOLDINGS, INC. FORM 8-K (Current report filing) Filed 06/30/14 for the Period Ending 06/30/14 Address 83 WOOSTER HEIGHTS ROAD DANBURY, CT 06810 Telephone 203-448-4600 CIK 0001595262 Symbol IMS

More information

INTERNATIONAL BANCSHARES CORPORATION (Exact Name of registrant as specified in its charter)

INTERNATIONAL BANCSHARES CORPORATION (Exact Name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest

More information

PACIFIC ETHANOL, INC. (Exact name of registrant as specified in its charter)

PACIFIC ETHANOL, INC. (Exact name of registrant as specified in its charter) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported)

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT #1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT #1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT #1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date

More information

SEQUENTIAL BRANDS GROUP, INC.

SEQUENTIAL BRANDS GROUP, INC. SEQUENTIAL BRANDS GROUP, INC. FORM 8-K (Current report filing) Filed 08/03/10 for the Period Ending 07/28/10 Address 1065 AVENUE OF AMERICAS SUITE 1705 NEW YORK, NY 10018 Telephone 213-745-2123 CIK 0000791770

More information

GRUBB & ELLIS HEALTHCARE REIT, INC.

GRUBB & ELLIS HEALTHCARE REIT, INC. GRUBB & ELLIS HEALTHCARE REIT, INC. FORM 8-K (Current report filing) Filed 04/21/09 for the Period Ending 04/21/09 Address 1551 N. TUSTIN AVENUE SUITE 300 SANTA ANA, CA 92705 Telephone 714-667-8252 CIK

More information

ANALOG DEVICES INC FORM 8-K. (Current report filing) Filed 06/18/15 for the Period Ending 06/17/15

ANALOG DEVICES INC FORM 8-K. (Current report filing) Filed 06/18/15 for the Period Ending 06/17/15 ANALOG DEVICES INC FORM 8-K (Current report filing) Filed 06/18/15 for the Period Ending 06/17/15 Address ONE TECHNOLOGY WAY NORWOOD, MA 02062 Telephone 7813294700 CIK 0000006281 Symbol ADI SIC Code 3674

More information

SECURITIES AND EXCHANGE COMMISSION FORM 8-K. Current report filing

SECURITIES AND EXCHANGE COMMISSION FORM 8-K. Current report filing SECURITIES AND EXCHANGE COMMISSION FORM 8-K Current report filing Filing Date: 2005-11-07 Period of Report: 2005-11-01 SEC Accession No. 0000950137-05-013397 (HTML Version on secdatabase.com) FILER PRINCIPAL

More information

GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS, INC.

GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS, INC. GLOBAL DEFENSE & NATIONAL SECURITY SYSTEMS, INC. FORM DEFA14A (Additional Proxy Soliciting Materials (definitive)) Filed 07/14/15 Address 11921 FREEDOM DRIVE, SUITE 550 TWO FOUNTAIN SQUARE RESTON, VA 20190

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

AMERUS GROUP CO/IA. FORM 8-K (Current report filing) Filed 8/15/2006 For Period Ending 8/14/2006

AMERUS GROUP CO/IA. FORM 8-K (Current report filing) Filed 8/15/2006 For Period Ending 8/14/2006 AMERUS GROUP CO/IA FORM 8-K (Current report filing) Filed 8/15/2006 For Period Ending 8/14/2006 Address 699 WALNUT STREET DES MOINES, Iowa 50309 Telephone 515-362-3600 CIK 0001051717 Industry Insurance

More information

BIOLIFE SOLUTIONS INC

BIOLIFE SOLUTIONS INC SECURITIES & EXCHANGE COMMISSION EDGAR FILING BIOLIFE SOLUTIONS INC Form: 8-K Date Filed: 2016-01-07 Corporate Issuer CIK: 834365 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution

More information

FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K. Summit State Bank (Exact name of registrant as specified in its charter)

FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K. Summit State Bank (Exact name of registrant as specified in its charter) FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

More information

SECURITIES & EXCHANGE COMMISSION EDGAR FILING ISSUER DIRECT CORP. Form: 8-K. Date Filed: 2013-07-08

SECURITIES & EXCHANGE COMMISSION EDGAR FILING ISSUER DIRECT CORP. Form: 8-K. Date Filed: 2013-07-08 SECURITIES & EXCHANGE COMMISSION EDGAR FILING ISSUER DIRECT CORP Form: 8-K Date Filed: 2013-07-08 Corporate Issuer CIK: 843006 Symbol: ISDR SIC Code: 2750 Fiscal Year End: 12/31 Copyright 2014, Issuer

More information

SPHERIX INC FORM 8-K. (Current report filing) Filed 05/24/16 for the Period Ending 05/23/16

SPHERIX INC FORM 8-K. (Current report filing) Filed 05/24/16 for the Period Ending 05/23/16 SPHERIX INC FORM 8-K (Current report filing) Filed 05/24/16 for the Period Ending 05/23/16 Address 1350 AVENUE OF THE AMERICAS FL 2 NEW YORK, NY 10019 Telephone 347-321-7646 CIK 0000012239 Symbol SPEX

More information

SPHERIX INCORPORATED (Exact Name of Registrant as Specified in Charter)

SPHERIX INCORPORATED (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UBIQUITY, INC. FORM 8-K. (Current report filing) Filed 03/20/15 for the Period Ending 03/19/15

UBIQUITY, INC. FORM 8-K. (Current report filing) Filed 03/20/15 for the Period Ending 03/19/15 UBIQUITY, INC. FORM 8-K (Current report filing) Filed 03/20/15 for the Period Ending 03/19/15 Address 9801 RESEARCH DRIVE IRVINE,, CA 92618 Telephone 7029970504 CIK 0001538329 Symbol UBIQ SIC Code 7374

More information

FEDERAL DEPOSIT INSURANCE CORPORATION. Washington, D.C. 20429 FORM 8-K CURRENT REPORT. PURSUANT TO SECTION 13 OR 15(d)

FEDERAL DEPOSIT INSURANCE CORPORATION. Washington, D.C. 20429 FORM 8-K CURRENT REPORT. PURSUANT TO SECTION 13 OR 15(d) FEDERAL DEPOSIT INSURANCE CORPORATION Washington, D.C. 20429 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

More information

GULFPORT ENERGY CORPORATION

GULFPORT ENERGY CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities exchange act of 1934 Date of report (Date of earliest event

More information

3D SYSTEMS CORP FORM 8-K. (Current report filing) Filed 07/30/14 for the Period Ending 07/30/14

3D SYSTEMS CORP FORM 8-K. (Current report filing) Filed 07/30/14 for the Period Ending 07/30/14 3D SYSTEMS CORP FORM 8-K (Current report filing) Filed 07/30/14 for the Period Ending 07/30/14 Address 333 THREE D SYSTEMS CIRCLE ROCK HILL, SC 29730 Telephone 8033263900 CIK 0000910638 Symbol DDD SIC

More information

AMERISAFE INC FORM 8-K. (Current report filing) Filed 04/29/15 for the Period Ending 04/29/15

AMERISAFE INC FORM 8-K. (Current report filing) Filed 04/29/15 for the Period Ending 04/29/15 AMERISAFE INC FORM 8-K (Current report filing) Filed 04/29/15 for the Period Ending 04/29/15 Address 2301 HIGHWAY 190 WEST DERIDDER, LA 70634 Telephone 337-463-9052 CIK 0001018979 Symbol AMSF SIC Code

More information

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter)

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 15, 2015 (Date

More information

IMPERIAL HOLDINGS, INC.

IMPERIAL HOLDINGS, INC. IMPERIAL HOLDINGS, INC. FORM 8-K (Current report filing) Filed 01/03/12 for the Period Ending 12/30/11 Address 701 PARK OF COMMERCE BOULEVARD SUITE 301 BOCA RATON, FL 33487 Telephone 561-995-4200 CIK 0001494448

More information

ACTINIUM PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter)

ACTINIUM PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 27, 2006 (April 25, 2006) Date

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported):

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

P. H. Glatfelter Company (Exact name of registrant as specified in its charter)

P. H. Glatfelter Company (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event

More information

Ladenburg Thalmann Financial Services Inc.

Ladenburg Thalmann Financial Services Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event

More information

LIFEVANTAGE CORP FORM 8-K. (Current report filing) Filed 07/20/06 for the Period Ending 07/17/06

LIFEVANTAGE CORP FORM 8-K. (Current report filing) Filed 07/20/06 for the Period Ending 07/17/06 LIFEVANTAGE CORP FORM 8-K (Current report filing) Filed 07/20/06 for the Period Ending 07/17/06 Address 11545 WEST BERNARDO COURT SUITE 301 SAN DIEGO, CA 92127 Telephone 858-312-8000 CIK 0000849146 Symbol

More information

MATTEL INC /DE/ FORM 8-K. (Current report filing) Filed 11/21/08 for the Period Ending 11/21/08

MATTEL INC /DE/ FORM 8-K. (Current report filing) Filed 11/21/08 for the Period Ending 11/21/08 MATTEL INC /DE/ FORM 8-K (Current report filing) Filed 11/21/08 for the Period Ending 11/21/08 Address 333 CONTINENTAL BLVD EL SEGUNDO, CA 90245 Telephone 3102522000 CIK 0000063276 Symbol MAT SIC Code

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

ROLLINS INC FORM 8-K. (Current report filing) Filed 05/09/13 for the Period Ending 05/07/13

ROLLINS INC FORM 8-K. (Current report filing) Filed 05/09/13 for the Period Ending 05/07/13 ROLLINS INC FORM 8-K (Current report filing) Filed 05/09/13 for the Period Ending 05/07/13 Address 2170 PIEDMONT RD NE ATLANTA, GA 30324 Telephone 4048882000 CIK 0000084839 Symbol ROL SIC Code 7340 - Services

More information

Form 8-K. Current Report. Caterpillar Financial Services Corporation

Form 8-K. Current Report. Caterpillar Financial Services Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

American Electric Technologies Inc

American Electric Technologies Inc SECURITIES & EXCHANGE COMMISSION EDGAR FILING American Electric Technologies Inc Form: 8-K Date Filed: 2015-11-16 Corporate Issuer CIK: 1043186 Copyright 2015, Issuer Direct Corporation. All Right Reserved.

More information

INGERSOLL RAND CO LTD

INGERSOLL RAND CO LTD INGERSOLL RAND CO LTD FORM 8-K (Current report filing) Filed 01/11/08 for the Period Ending 01/10/08 Address 155 CHESTNUT RIDGE ROAD MONTVALE, NJ 07645 Telephone 2015730123 CIK 0001160497 Symbol IR SIC

More information

SBA COMMUNICATIONS CORP

SBA COMMUNICATIONS CORP SBA COMMUNICATIONS CORP FORM 8-K (Current report filing) Filed 12/26/12 for the Period Ending 12/26/12 Address 5900 BROKEN SOUND PARKWAY BOCA RATON, FL 33487 Telephone 5619957670 CIK 0001034054 Symbol

More information

DIRECTV HOLDINGS LLC

DIRECTV HOLDINGS LLC DIRECTV HOLDINGS LLC FORM 8-A12B (Securities Registration (section 12(b))) Filed 11/21/13 Address 2260 E. IMPERIAL HIGHWAY EL SEGUNDO, CA 90245 Telephone 310-964-0724 CIK 0001234308 SIC Code 4841 - Cable

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

EDWARDS LIFESCIENCES CORP

EDWARDS LIFESCIENCES CORP EDWARDS LIFESCIENCES CORP FORM 8-K (Current report filing) Filed 11/14/14 for the Period Ending 11/13/14 Address ONE EDWARDS WAY IRVINE, CA 92614 Telephone 9492502500 CIK 0001099800 Symbol EW SIC Code

More information

AMERICAN EXPRESS COMPANY

AMERICAN EXPRESS COMPANY AXP 8-K 1/15/2016 Section 1: 8-K (FORM 8-K OF AMERICAN EXPRESS COMPANY) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of

More information

NORTHROP GRUMMAN CORP /DE/

NORTHROP GRUMMAN CORP /DE/ NORTHROP GRUMMAN CORP /DE/ FORM 8-K (Current report filing) Filed 02/07/13 for the Period Ending 02/06/13 Address 2980 FAIRVIEW PARK DRIVE C/O NORTHROP GRUMMAN CORP FALLS CHURCH, VA 22042 Telephone 703-280-2900

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

COSTCO WHOLESALE CORPORATION (Exact name of registrant as specified in its charter)

COSTCO WHOLESALE CORPORATION (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event

More information

EVERYDAY HEALTH, INC.

EVERYDAY HEALTH, INC. EVERYDAY HEALTH, INC. FORM 8-K (Current report filing) Filed 05/11/15 for the Period Ending 05/11/15 Address 345 HUDSON STREET 16TH FLOOR NEW YORK, NY 10014 Telephone 718-797-0722 CIK 0001358483 Symbol

More information

FEDERAL DEPOSIT INSURANCE CORPORATION WASHINGTON, D.C. 20429 FORM 8-K

FEDERAL DEPOSIT INSURANCE CORPORATION WASHINGTON, D.C. 20429 FORM 8-K FEDERAL DEPOSIT INSURANCE CORPORATION WASHINGTON, D.C. 20429 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported)

More information

LOJACK CORP FORM 8-K. (Current report filing) Filed 10/19/12 for the Period Ending 10/18/12

LOJACK CORP FORM 8-K. (Current report filing) Filed 10/19/12 for the Period Ending 10/18/12 LOJACK CORP FORM 8-K (Current report filing) Filed 10/19/12 for the Period Ending 10/18/12 Address 40 PEQUOT WAY CANTON, MA 02021 Telephone 781-302-4200 CIK 0000355777 Symbol LOJN SIC Code 3669 - Communications

More information

XENOPORT INC FORM 8-K. (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14

XENOPORT INC FORM 8-K. (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14 XENOPORT INC FORM 8-K (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14 Address 3410 CENTRAL EXPRESSWAY SANTA CLARA, CA 95051 Telephone 4086167200 CIK 0001130591 Symbol XNPT SIC Code

More information

BOOZ ALLEN HAMILTON HOLDING CORP

BOOZ ALLEN HAMILTON HOLDING CORP BOOZ ALLEN HAMILTON HOLDING CORP FORM 8-K (Current report filing) Filed 01/31/14 for the Period Ending 01/31/14 Address 8283 GREENSBORO DRIVE MCLEAN, VA 22102 Telephone 703-902-5000 CIK 0001443646 Symbol

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

ARIAD Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter)

ARIAD Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

SORRENTO THERAPEUTICS, INC.

SORRENTO THERAPEUTICS, INC. ˆ200F@WVSVmdG1Yng+Š 200F@WVSVmdG1Yng+ AZ0151AC599817 11.3.10 SWRvelaj0nb 31-Jul-2013 16:51 EST 577580 TX 1 3* UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 CURRENT REPORT Pursuant

More information

APPLE INC FORM 8-K. (Current report filing) Filed 10/27/15 for the Period Ending 10/27/15

APPLE INC FORM 8-K. (Current report filing) Filed 10/27/15 for the Period Ending 10/27/15 APPLE INC FORM 8-K (Current report filing) Filed 10/27/15 for the Period Ending 10/27/15 Address ONE INFINITE LOOP CUPERTINO, CA 95014 Telephone (408) 996-1010 CIK 0000320193 Symbol AAPL SIC Code 3571

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

AMERICAN EXPRESS COMPANY (Exact name of registrant as specified in its charter)

AMERICAN EXPRESS COMPANY (Exact name of registrant as specified in its charter) AXP 8-K 2/29/2016 Section 1: 8-K (FORM 8-K OF AMERICAN EXPRESS COMPANY) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of

More information

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter)

FEDERATED NATIONAL HOLDING COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 9, 2014 (Date

More information

Victory Energy Corporation (Exact name of registrant as specified in its charter)

Victory Energy Corporation (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

SOUTH JERSEY INDUSTRIES INC

SOUTH JERSEY INDUSTRIES INC SOUTH JERSEY INDUSTRIES INC FORM 8-K (Current report filing) Filed 12/05/14 for the Period Ending 12/05/14 Address #1 SOUTH JERSEY PLAZA ROUTE 54 FOLSOM, NJ 08037 Telephone 6095619000 CIK 0000091928 Symbol

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

NVIDIA CORP FORM 8-K. (Current report filing) Filed 05/26/15 for the Period Ending 05/20/15

NVIDIA CORP FORM 8-K. (Current report filing) Filed 05/26/15 for the Period Ending 05/20/15 NVIDIA CORP FORM 8-K (Current report filing) Filed 05/26/15 for the Period Ending 05/20/15 Address 2701 SAN TOMAS EXPRESSWAY SANTA CLARA, CA 95050 Telephone 408-486-2000 CIK 0001045810 Symbol NVDA SIC

More information

AMN HEALTHCARE SERVICES INC

AMN HEALTHCARE SERVICES INC AMN HEALTHCARE SERVICES INC FORM 8-K (Current report filing) Filed 02/19/15 for the Period Ending 02/19/15 Address 12400 HIGH BLUFF DRIVE SUITE 100 SAN DIEGO, CA 92130 Telephone 8668718519 CIK 0001142750

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K/A. Vanguard Natural Resources, LLC (Exact name of registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K/A. Vanguard Natural Resources, LLC (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest

More information

LMI AEROSPACE INC FORM 8-K. (Current report filing) Filed 05/09/16 for the Period Ending 05/09/16

LMI AEROSPACE INC FORM 8-K. (Current report filing) Filed 05/09/16 for the Period Ending 05/09/16 LMI AEROSPACE INC FORM 8-K (Current report filing) Filed 05/09/16 for the Period Ending 05/09/16 Address 411 FOUNTAIN LAKES BLVD. ST CHARLES, MO 63301 Telephone 636-946-6525 CIK 0001059562 Symbol LMIA

More information

NORDSON CORP FORM 8-K. (Current report filing) Filed 06/14/12 for the Period Ending 06/14/12

NORDSON CORP FORM 8-K. (Current report filing) Filed 06/14/12 for the Period Ending 06/14/12 NORDSON CORP FORM 8-K (Current report filing) Filed 06/14/12 for the Period Ending 06/14/12 Address 28601 CLEMENS RD WESTLAKE, OH 44145 Telephone 4408921580 CIK 0000072331 Symbol NDSN SIC Code 3569 - General

More information

NEVADA GOLD & CASINOS INC

NEVADA GOLD & CASINOS INC NEVADA GOLD & CASINOS INC FORM 8-K (Current report filing) Filed 08/30/05 for the Period Ending 08/24/05 Address 50 BRIAR HOLLOW LANE, SUITE 500W HOUSTON, TX 77027 Telephone (713) 621-2245 CIK 0000277058

More information

DIFFUSION PHARMACEUTICALS INC.

DIFFUSION PHARMACEUTICALS INC. DIFFUSION PHARMACEUTICALS INC. FORM 8-K (Current report filing) Filed 03/07/14 for the Period Ending 03/07/14 Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE, VA 22902 Telephone (434) 220-0718 CIK 0001053691

More information